Update Information on Human P450s

REFERENCES

• Distlerath L.M., Guengerich F.P. Enzymology of Human Liver Cytochromes P-450. Mammalian Cytochromes P-450, F.P. Guengerich. CRC Press, Boca Raton, Florida 1987; Vol. 1: 133–198
   Google Scholar
• Kaschnitz R.M., Coon M.J. Drug and Fatty Acid Hydroxylation by Solubilized Human Liver Microsomal Cytochrome P-450: Phospholipid Requirement. Biochem. Pharmacol. 1975; 24: 295–297
   PubMed Web of Science ®Google Scholar
• Distlerath L.M., Reilly P.E.B., Martin M.V., Davis G.G., Wilkinson G.R., Guengerich F.P. Purification and Characterization of the Human Liver Cytochromes P-450 Involved in Debrisoquine 4-Hydroxylation and Phenacetin O-Deethylation, Two Prototypes for Genetic Polymorphism in Oxidative Drug Metabolism. J. Biol. Chem. 1985; 260: 9057–9067
   PubMed Web of Science ®Google Scholar
• Gut J., Gasser R., Dayer P., Kronbach T., Catin T., Meyer U.A. Debrisoquine-Type Polymorphism of Drug Oxidation: Purification from Human Liver of a Cytochrome P450 Isozyme with High Activity for Bufuralol Hydroxylation. FEBS Lett. 1984; 173: 287–290
   PubMed Web of Science ®Google Scholar
• Gut J., Catin T., Dayer P., Kronbach T., Zanger U., Meyer U.A. Debrisoquine/Sparteine-Type Polymorphism of Drug Oxidation: Purification and Characterization of Two Functionally Different Human Liver Cytochrome P-450 Isozymes Involved in Impaired Hydroxylation of the Prototype Substrate Bufuralol. J. Biol. Chem. 1986; 261: 11734–11743
   PubMed Web of Science ®Google Scholar
• Birgersson C., Morgan E.T., Jörnvall H., von Bahr C. Purification of a Desmethylimipramine and Debrisoquine Hydroxylating Cytochrome P-450 from Human Liver. Biochem. Pharmacol. 1986; 35: 3165–3166
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Martin M.V., Beaune P.H., Kremers P., Wolff T., Waxman D.J. Characterization of Rat and Human Liver Microsomal Cytochrome P-450 Forms Involved in Nifedipine Oxidation, a Prototype for Genetic Polymorphism in Oxidative Drug Metabolism. J. Biol. Chem. 1986; 261: 5051–5060
   PubMed Web of Science ®Google Scholar
• Shimada T., Misono K.S., Guengerich F.P. Human Liver Microsomal Cytochrome P-450 Mephenytoin 4-Hydroxylase, a Prototype of Genetic Polymorphism in Oxidative Drug Metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 1986; 261: 909–921
   PubMed Web of Science ®Google Scholar
• Knodell R.G., Hall S.D., Wilkinson G.R., Guengerich F.P. Hepatic Metabolism of Tolbutamide: Characterization of the Form of Cytochrome P-450 Involved in Methyl Hydroxylation and Relationship to In Vivo Disposition. J. Pharmacol. Exp. Ther. 1987; 241: 1112–1119
   PubMed Web of Science ®Google Scholar
• Yun C-H., Shimada T., Guengerich F.P. Purification and Characterization of Human Liver Microsomal Cytochrome P-450 2A6. Mol. Pharmacol. 1991; 40: 679–685
   PubMed Web of Science ®Google Scholar
• Thomas P.E., Lu A.Y.H., West S.B., Ryan D., Miwa G.T., Levin W. Accessibility of Cytochrome P450 in Microsomal Membranes: Inhibition of Metabolism by Antibodies to Cytochrome P450. Mol. Pharmacol. 1977; 13: 819–831
   PubMed Web of Science ®Google Scholar
• Robie-Suh K., Robinson R., Gelboin H.V., Guengerich F.P. Aryl Hydrocarbon Hydroxylase Is Inhibited by Antibody to Rat Liver Cytochrome P-450. Science 1980; 208: 1031–1033
   PubMed Web of Science ®Google Scholar
• Distlerath L.M., Guengerich F.P. Characterization of a Human Liver Cytochrome P-450 Involved in the Oxidation of Debrisoquine and Other Drugs Using Antibodies Raised to the Analogous Rat Enzyme. Proc. Natl Acad. Sci. USA 1984; 81: 7348–7352
   PubMed Web of Science ®Google Scholar
• Gonzalez F.J., Matsunaga T., Nagata K., Meyer U.A., Nebert D.W., Pastewka J., Kozak C.A., Gillette J., Gelboin H.V., Hardwick J.P. Debrisoquine 4-Hydroxylase: Characterization of a New P450 Gene Subfamily, Regulation, Chromosomal Mapping, and Molecular Analysis of the DA Rat Polymorphism. DNA 1987; 6: 149–161
   PubMedGoogle Scholar
• Yamano S., Tatsuno J., Gonzalez F.J. The CYP2A3 Gene Product Catalyzes Coumarin 7-Hydroxylation in Human Liver Microsomes. Biochemistry 1990; 29: 1322–1329
   PubMed Web of Science ®Google Scholar
• Beaune P.H., Umbenhauer D.R., Bork R.W., Lloyd R.S., Guengerich F.P. Isolation and Sequence Determination of a cDNA Clone Related to Human Cytochrome P-450 Nifedipine Oxidase. Proc. Natl Acad. Sci. USA 1986; 83: 8064–8068
   PubMed Web of Science ®Google Scholar
• Ryan D.E., Thomas P.E., Korzeniowski D., Levin W. Separation and Characterization of Highly Purified Forms of Liver Microsomal Cytochrome P-450 from Rats Treated with Polychlorinated Biphenyls, Phenobarbital, and 3-Methylcholanthrene. J. Biol. Chem. 1979; 254: 1365–1374
   PubMed Web of Science ®Google Scholar
• Johnson E.F., Muller-Eberhard U. Multiple Forms of Cytochrome P-450: Resolution and Purification of Rabbit Liver Aryl Hydrocarbon Hydroxylase. Biochem. Biophys. Res. Commun. 1977; 76: 644–651
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Dannan G.A., Wright S.T., Martin M.V., Kaminsky L.S. Purification and Characterization of Liver Microsomal Cytochromes P-450: Electrophoretic, Spectral, Catalytic, and Immunochemical Properties and Inducibility of Eight Isozymes Isolated from Rats Treated with Phenobarbital or β-Naphthoflavone. Biochemistry 1982; 21: 6019–6030
   PubMed Web of Science ®Google Scholar
• Haugen D.A., van der Hoeven T.A., Coon M.J. Purified Liver Microsomal Cytochrome P-450: Separation and Characterization of Multiple Forms. J. Biol. Chem. 1975; 250: 3567–3570
   PubMed Web of Science ®Google Scholar
• Nakajin S., Shinoda M., Haniu M., Shively J.E., Hall P.F. C21 Steroid Side Chain Cleavage Enzyme for Porcine Adrenal Microsomes: Purification and Characterization of the 17a-Hydroxylase/C17,20-lyase Cytochrome P-450. J. Biol. Chem. 1984; 259: 3971–3976
   PubMed Web of Science ®Google Scholar
• Kellis J.T., Jr., Vickery L.E. Purification and Characterization of Human Placental Aromatase Cytochrome P-450. J. Biol. Chem. 1987; 262: 4413–4420
   PubMed Web of Science ®Google Scholar
• Maxam A.M., Gilbert W. A New Method for Sequencing DNA. Proc. Natl Acad. Sci. USA 1977; 74: 560–564
   PubMed Web of Science ®Google Scholar
• Sanger F., Nicklen S., Coulson A.R. DNA Sequencing with Chain-Terminatiing Inhibitors. Proc. Natl Acad. Sci. USA 1977; 74: 5463–6467
   PubMed Web of Science ®Google Scholar
• Turesky R.J., Constable A., Richoz J., Vargu N., Markovic J., Martin M.V., Guengerich F.P. Differences in Activation of Heterocyclic Aromatic Amines by Rat and Human Liver Microsomes and by Rat and Human Cytochromes P450 1A2. Chem. Res. Toxicol. 1998; 11: 925–936
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Comparisons of Catalytic Selectivity of Cytochrome P450 Subfamily Members from Different Species. Chem.-Biol. Interact. 1997; 106: 161–182
   PubMed Web of Science ®Google Scholar
• Bogaards J.J.P., Bertrand M., Jackson P., Oudshoorn M.J., Weaver R.J., van Bladeren P.J., Walther B. Determining the Best Animal Model for Human Cytochrome P450 Activities: a Comparison of Mouse, Rat, Rabbit, Dog, Micropig, Monkey and Man. Xenobiotica 2000; 30: 1131–1152
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Shimada T. Oxidation of Toxic and Carcinogenic Chemicals by Human Cytochrome P-450 Enzymes. Chem. Res. Toxicol. 1991; 4: 391–407
   PubMed Web of Science ®Google Scholar
• Cribb A., Nuss C., Wang R. Antipeptide Antibodies Against Overlapping Sequences Differentially Inhibit Human CYP2D6. Drug Metab. Dispos. 1995; 23: 671–675
   PubMed Web of Science ®Google Scholar
• Wang R.W., Lu A.Y.H. Inhibitory Anti-peptide Antibody Against Human CYP3A4. Drug Metab. Dispos. 1997; 25: 762–767
   PubMed Web of Science ®Google Scholar
• Yang T.J., Sai Y., Krausz K.W., Gonzalez F.J., Gelboin H.V. Inhibitory Monoclonal Antibodies to Human Cytochrome P450 1A2: Analysis of Phenacetin O-deethylation in Human Liver. Pharmacogenetics 1998; 8: 375–382
   PubMedGoogle Scholar
• Yang T.J., Krausz K.W., Sai Y., Gonzalez F.J., Gelboin H.V. Eight Inhibitory Monoclonal Antibodies Define the Role of Individual P-450s in Human Liver Microsomal Diazepam 7-Ethoxycoumarin, and Imipramine Metabolism. Drug Metab. Dispos. 1999; 27: 102–109
   PubMed Web of Science ®Google Scholar
• Halpert J. R., Guengerich F.P. Enzyme Inhibition and Stimulation. Biotransformation, F.P. Guengerich. Elsevier Science Ltd, Oxford 1997; Vol. 3: 21–35
   Google Scholar
• Gonzalez F.J., Crespi C.L., Gelboin H.V. cDNA-Expressed Human Cytochrome P450s: a New Age of Molecular Toxicology and Human Risk Assessment. Mutation Res. 1991; 247: 113–127
   PubMed Web of Science ®Google Scholar
• Barnes H.J., Jenkins C.M., Waterman M.R. Baculovirus Expression of Bovine Cytochrome P450c17 in Sf9 Cells and Comparison with Expression in Yeast, Mammalian Cells, and E. coli. Arch. Biochem. Biophys. 1994; 315: 489–494
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Gillam E.M.J., Shimada T. New Applications of Bacterial Systems to Problems in Toxicology. Crit. Rev. Toxicol. 1996; 26: 551–583
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Martin M.V., Guo Z., Chun Y.-J. Purification of Recombinant Human Cytochrome P450 Enzymes Expressed in Bacteria. Methods Enzymol. 1996; 272: 35–44
   PubMed Web of Science ®Google Scholar
• Parikh A., Gillam E.M.J., Guengerich F.P. Drug Metabolism by Escherichia coli Expressing Human Cytochromes P450. Nat. Biotechnol. 1997; 15: 784–788
   PubMed Web of Science ®Google Scholar
• Pritchard M.P., Glancey M.J., Blake J.A.R., Gilham D.E., Burchell B., Wolf C.R., Friedburg T. Functional Co-Expression of CYP2D6 and Human NADPH-Cytochrome P450 Reductase in Escherichia coli. Pharmacogenetics 1998; 8: 33–42
   PubMedGoogle Scholar
• Blake J.A.R., Pritchard M., Ding S., Smith G.C.M., Burchell B., Wolf C.R., Friedberg T. Coexpression of a Human P450 (CYP3A4) and P450 Reductase Generates a Highly Functional Monooxygenase System in Escherichia coli. FEBS Lett. 1996; 397: 210–214
   PubMed Web of Science ®Google Scholar
• Bell-Parikh L.C., Guengerich F.P. Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid Via Acetaldehyde. J. Biol. Chem. 1999; 274: 23833–23840
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity. Chem. Res. Toxicol. 2001; 14: 611–650
   PubMed Web of Science ®Google Scholar
• Northrop D.B. On the Meaning of Km and V/K in Enzyme Kinetics. J. Chem. Ed. 1998; 75: 1153–1157
   Web of Science ®Google Scholar
• Kalow W. Pharmacogenetics: Heredity and the Response to Drugs. W.B. Saunders, Philadelphia 1962
   Google Scholar
• White P.C., New M.I., Dupont B. HLA-Linked Congenital Adrenal Hyperplasia Results from a Defective Gene Encoding a Cytochrome P-450 Specific for Steroid 21-Hydroxylation. Proc. Natl Acad. Sci. USA 1984; 81: 7505–7509
   PubMed Web of Science ®Google Scholar
• Higashi Y., Hiromasa T., Tanae A., Miki T., Nakura J., Kondo T., Ohura T., Ogawa E., Nakayama K., Fujii-Kuriyama Y. Effects of Individual Mutations in the P-450 (C21) Pseudogene on the P-450 (C21) Activity and their Distribution in the Patient Genomes of Congenital Steroid 21-Hydroxylase Deficiency. J. Biochem. 1991; 109: 638–644
   PubMed Web of Science ®Google Scholar
• Johansson I., Lundqvist E., Bertilsson L., Dahl M.L., Sjoqvist F., Ingelman-Sundberg M. Inherited Amplification of an Active Gene in the Cytochrome P450 CYP2D Locus as a Cause of Ultrarapid Metabolism of Debrisoquine. Proc. Natl Acad. Sci. USA 1993; 90: 11825–11829
   PubMed Web of Science ®Google Scholar
• Steward D.J., Haining R.L., Henne K.R., Davis G., Rushmore T.H., Trager W.F., Rettie A.E. Genetic Association Between Sensitivity to Warfarin and Expression of CYP2C9*3. Pharmacogenetics 1997; 7: 361–367
   PubMedGoogle Scholar
• Wong B.K., Goldstein J., Spielberg S.P., Rushmore T.H. Characterization of an In Vitro Model for Assessing Polymorphic Metabolism by CYP2C9: Involvement in the Mechanism of Deficient Losartan Metabolism. ISSX Proc. 1996; 10: 236
   Google Scholar
• Lindberg R.L.P., Negishi M. Alteration of Mouse Cytochrome P450coh Substrate Specificity by Mutation of a Single Amino-Acid Residue. Nature 1989; 339: 632–634
   PubMed Web of Science ®Google Scholar
• Kronbach T., Larabee T.M., Johnson E.F. Hybrid Cytochromes P-450 Identify a Substrate Binding Domain in P-450IIC5 and P-450IIC4. Proc. Natl Acad. Sci. USA 1989; 86: 8262–8265
   PubMed Web of Science ®Google Scholar
• Parikh A., Josephy P.D., Guengerich F.P. Selection and Characterization of Human Cytochrome P450 1A2 Mutants with Altered Catalytic Properties. Biochemistry 1999; 38: 5283–5289
   PubMed Web of Science ®Google Scholar
• Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative Amino Acid Substitution Variants Exist at Polymorphic Frequency in DNA Repair Genes in Healthy Humans. Cancer Res. 1998; 58: 604–608
   PubMed Web of Science ®Google Scholar
• Marichal P., Koymans L., Willemsens S., Bellens D., Verhasselt P., Luyten W., Borgers M., Ramaekers F.C.S., Odds F.C., Vanden Bosche H. Contribution of Mutations in the Cytochrome P450 14 -Demethylase (Erg11p, Cyp51p) to Azole Resistance in Candida albicans. Microbiology 1999; 145: 2701–2713
   PubMed Web of Science ®Google Scholar
• d'Errico A., Taioli E., Chen X., Vineis P. Genetic Metabolic Polymorphisms and the Risk of Cancer: A Review of the Literature. BioMarkers 1996; 1: 149–173
   PubMed Web of Science ®Google Scholar